Article
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
7 Jul 2022
Abstract excerpt
Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response to COVID-19. The emergence of hypermutated, increasingly transmissible variants of concern (VOCs) threaten this strategy. Omicron (B.1.1.529), the fifth VOC to be described, harbours multiple amino acid mutations in spike, half of which lie within the receptor-binding domain. Here we demonstrate substantial evasion...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
